News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Sanofi-Aventis (France) and Merck & Co., Inc. Begin Vet Drugs Sale
October 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Oct 21 (Reuters) - Merck & Co Inc (MRK.N) and Sanofi-Aventis SA (SASY.PA) have begun selling parts of the businesses they are combining to form the world's largest animal-health operation, people familiar with the matter said.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Merck & Co.
Sanofi (France)
MORE ON THIS TOPIC
Rare diseases
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition
October 27, 2025
·
2 min read
·
Tristan Manalac
M&A
Novartis To ‘Bolster’ Neuromuscular Pipeline With $12B Avidity Acquisition
October 26, 2025
·
2 min read
·
Heather McKenzie
Immunology and inflammation
Biogen Grows Immunology Pipeline With Vanqua’s Anti-Inflammatory Molecule
October 24, 2025
·
2 min read
·
Dan Samorodnitsky
Deals
Lilly Dives Deeper Into Gene Therapy With up to $262M Adverum Buy
October 24, 2025
·
2 min read
·
Heather McKenzie